SCHEMBL16627428

SCHEMBL16627428

O=Cc1cccnc1Nc1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 3/20 0.49
GAA P10253 3/20 0.49
ALDH1A1 P00352 3/20 0.49
NPSR1 Q6W5P4 3/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
RECQL P46063 1/20 0.49
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44
TUBA3E Q6PEY2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1376342 0.85 DHODH (0.56) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL10835241 0.84 RAB9A (0.56) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL9402383 0.84 RAB9A (0.57) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL9402324 0.84 DHODH (0.57) MEN1KMT2AMAPTLMNATUBB4A
SCHEMBL10677709 0.80 ABCG2 (0.47) ALDH1A1NPSR1POLBDHODHABCG2
SCHEMBL8835483 0.80 RAB9A (0.60) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL16627388 0.80 MAPT (0.45) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL16627427 0.79 ABCG2 (0.50) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL6644285 0.77 MAP4K4 (0.43) KMT2AMAPTHTTDHODHRAB9A
SCHEMBL16627415 0.77 GAA (0.56) MEN1KMT2AMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 MEN1 2511/4885KMT2A 2973/4885MAPT 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.